Allyson D. Roe

3.2k total citations · 1 hit paper
22 papers, 2.2k citations indexed

About

Allyson D. Roe is a scholar working on Physiology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Allyson D. Roe has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 8 papers in Psychiatry and Mental health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Allyson D. Roe's work include Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). Allyson D. Roe is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). Allyson D. Roe collaborates with scholars based in United States, Switzerland and United Kingdom. Allyson D. Roe's co-authors include Bradley T. Hyman, Sarah L. DeVos, Susanne Wegmann, Caitlin Commins, Rachel E. Bennett, Simon Dujardin, Daniel J. Müller, Rose Pitstick, George A. Carlson and Zhanyun Fan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Neuroscience.

In The Last Decade

Allyson D. Roe

22 papers receiving 2.1k citations

Hit Papers

Tau protein liquid–liquid phase separation can initiate t... 2018 2026 2020 2023 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allyson D. Roe United States 18 1.3k 1.1k 517 435 213 22 2.2k
Caitlin Commins United States 14 1.1k 0.9× 1.2k 1.1× 393 0.8× 501 1.2× 204 1.0× 21 2.1k
Sneha Narasimhan United States 18 1.3k 1.0× 638 0.6× 729 1.4× 456 1.0× 246 1.2× 23 2.0k
Hwan‐Ching Tai Taiwan 19 1.1k 0.8× 1.1k 1.0× 365 0.7× 573 1.3× 162 0.8× 41 2.3k
Yukio Matsuba Japan 14 1.6k 1.2× 841 0.8× 556 1.1× 493 1.1× 170 0.8× 25 2.3k
Catherine L. Clelland United States 13 1.2k 0.9× 802 0.7× 453 0.9× 575 1.3× 264 1.2× 17 2.0k
Jennifer D. McBride United States 11 1.7k 1.3× 772 0.7× 718 1.4× 508 1.2× 368 1.7× 13 2.2k
Estibaliz Capetillo‐Zarate Spain 26 1.4k 1.1× 791 0.7× 784 1.5× 797 1.8× 263 1.2× 44 2.6k
Tritia R. Yamasaki United States 12 1.4k 1.1× 860 0.8× 721 1.4× 720 1.7× 341 1.6× 20 2.4k
Carol A. Miller United States 17 950 0.7× 752 0.7× 616 1.2× 486 1.1× 167 0.8× 28 1.9k
Robert M. Koffie United States 12 1.4k 1.1× 668 0.6× 459 0.9× 700 1.6× 274 1.3× 23 2.2k

Countries citing papers authored by Allyson D. Roe

Since Specialization
Citations

This map shows the geographic impact of Allyson D. Roe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allyson D. Roe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allyson D. Roe more than expected).

Fields of papers citing papers by Allyson D. Roe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allyson D. Roe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allyson D. Roe. The network helps show where Allyson D. Roe may publish in the future.

Co-authorship network of co-authors of Allyson D. Roe

This figure shows the co-authorship network connecting the top 25 collaborators of Allyson D. Roe. A scholar is included among the top collaborators of Allyson D. Roe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allyson D. Roe. Allyson D. Roe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wegmann, Susanne, Bahareh Eftekharzadeh, Katharina Tepper, et al.. (2018). Tau protein liquid–liquid phase separation can initiate tau aggregation. The EMBO Journal. 37(7). 769 indexed citations breakdown →
2.
Kara, Eleanna, Allyson D. Roe, Caitlin Commins, et al.. (2018). A flow cytometry–based in vitro assay reveals that formation of apolipoprotein E (ApoE)–amyloid beta complexes depends on ApoE isoform and cell type. Journal of Biological Chemistry. 293(34). 13247–13256. 11 indexed citations
3.
Hopp, Sarah C., Derek H. Oakley, Allyson D. Roe, et al.. (2018). The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease. Journal of Neuroinflammation. 15(1). 269–269. 209 indexed citations
4.
DeVos, Sarah L., Bianca T. Corjuc, Caitlin Commins, et al.. (2018). Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo. Brain. 141(7). 2194–2212. 79 indexed citations
5.
Wu, Hsin‐Yi, Yi‐Ting Wang, Allyson D. Roe, et al.. (2018). β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals. Journal of Neuropathology & Experimental Neurology. 77(9). 814–826. 47 indexed citations
6.
Kara, Eleanna, Zhanyun Fan, Jacob A. Klickstein, et al.. (2017). Isoform- and cell type-specific structure of apolipoprotein E lipoparticles as revealed by a novel Forster resonance energy transfer assay. Journal of Biological Chemistry. 292(36). 14720–14729. 17 indexed citations
7.
Nicholls, Samantha B., Sarah L. DeVos, Caitlin Commins, et al.. (2017). Characterization of TauC3 antibody and demonstration of its potential to block tau propagation. PLoS ONE. 12(5). e0177914–e0177914. 31 indexed citations
8.
Bennett, Rachel E., Sarah L. DeVos, Simon Dujardin, et al.. (2017). Enhanced Tau Aggregation in the Presence of Amyloid β. American Journal Of Pathology. 187(7). 1601–1612. 183 indexed citations
9.
Takeda, Shuko, Caitlin Commins, Sarah L. DeVos, et al.. (2016). Seed‐competent high‐molecular‐weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients. Annals of Neurology. 80(3). 355–367. 82 indexed citations
10.
Takeda, Shuko, Susanne Wegmann, Hansang Cho, et al.. (2015). Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer’s disease brain. Nature Communications. 6(1). 8490–8490. 276 indexed citations
11.
Wegmann, Susanne, Eduardo A. Maury, Molly J. Kirk, et al.. (2015). Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity. The EMBO Journal. 34(24). 3028–3041. 93 indexed citations
12.
Chhatwal, Jasmeer P., Aaron P. Schultz, Gad A. Marshall, et al.. (2015). O4‐01‐04: Entorhinal, parahippocampal, and inferior temporal F18‐T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly. Alzheimer s & Dementia. 11(7S_Part_6). 2 indexed citations
13.
Chhatwal, Jasmeer P., Aaron P. Schultz, Gad A. Marshall, et al.. (2015). IC‐P‐162: Entorhinal, parahippocampal, and inferior temporal F18‐T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly. Alzheimer s & Dementia. 11(7S_Part_2). 2 indexed citations
14.
Zhang, Cheng, et al.. (2015). Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease. Journal of Alzheimer s Disease. 45(4). 1175–1184. 35 indexed citations
15.
Spires‐Jones, Tara L., Rose Pitstick, Manuela Polydoro, et al.. (2014). Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy. Neuroscience Letters. 562. 63–68. 31 indexed citations
16.
Donohue, Michael, Setareh H. Moghadam, Allyson D. Roe, et al.. (2014). Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials. Alzheimer s & Dementia. 11(9). 1069–1079. 24 indexed citations
17.
Zhang, Cheng, Allyson D. Roe, Kenner C. Rice, et al.. (2014). Increased Tau Phosphorylation and Aggregation in the Hippocampus of Mice Overexpressing Corticotropin-Releasing Factor. Journal of Alzheimer s Disease. 43(3). 967–976. 39 indexed citations
18.
Polydoro, Manuela, Alix de Calignon, Marc Suárez‐Calvet, et al.. (2013). Reversal of Neurofibrillary Tangles and Tau-Associated Phenotype in the rTgTauEC Model of Early Alzheimer's Disease. Journal of Neuroscience. 33(33). 13300–13311. 37 indexed citations
19.
Takeda, Shuko, Tadafumi Hashimoto, Allyson D. Roe, et al.. (2013). Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease. The FASEB Journal. 27(8). 3239–3248. 50 indexed citations
20.
Roe, Allyson D., et al.. (2011). Lipopolysaccharide-induced tau phosphorylation and kinase activity - modulation, but not mediation, by corticotropin-releasing factor receptors. European Journal of Neuroscience. 34(3). 448–456. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026